Christian Steidl

Researcher

Related Research

Related News & Events

Press Release|November 29, 2022

Five outstanding research teams share $22.4 million in funding of two new and three renewal Terry Fox New Frontiers Program Project Grants in 2022 competition

Five Canadian cancer research teams will share $22.4 million to expand their research into key areas of cancer treatment after winning the 2022 Terry ...

Research Highlight|November 01, 2021

Lymphoma PPG team presents updates during first event of TFRI's Pan-Can Seminar Series

Members of TFRI's BC-based Terry Fox New Frontiers Program Project Grant in Overcoming treatment failure in lymphoid cancers presented during the firs...

Research Highlight|October 21, 2021

Lymphoma team publishes two papers on diffuse large B-cell lymphoma in major journal

Both papers help to better understand diffuse large B-cell lymphoma (DLBCL), a heterogeneous form of non-Hodgkin lymphoma that has an average five-yea...

TFRI News|August 17, 2020

Marathon of Hope Cancer Centres Network operational plan continues to take shape

Plans for implementation of the new pan-Canadian network to accelerate precision medicine continue to move ahead with partners and leaders from the fo...

Research Highlight|August 05, 2020

Researchers identify mutation associated with improved survival in Diffuse Large B-cell Lymphoma

BC-based researchers have found that TMEM30A loss affects the cell membrane, allowing drugs to be delivered into cancer cells more effectively and imp...

Research Highlight|January 14, 2020

New discovery reveals how Hodgkin lymphoma avoids attack from immune cells

A team of lymphoma researchers partly funded by the TFRI has discovered a unique way in which Hodgkin lymphoma cells interact with regular immune cell...

Research Highlight|January 09, 2020

Newly created synthetic cancer cells help advance understanding of leukemias

For the first time ever, a team of TFRI-funded researchers has created synthetic cancer cells that are indistinguishable from T-cell acute lymphoblast...

Research Highlight|June 03, 2019

EZH2 inhibitors could make immunotherapies more effective for a subset of patients with diffuse large B-cell lymphoma

A study by a group of BC-based scientists partly funded by the TFRI has discovered mutations responsible for changes in expression of major histocompa...

Research Highlight|May 15, 2018

Researchers develop groundbreaking targeted sequencing pipeline to further precision medicine in lymphoid cancers

A cancer research team funded partly by The Terry Fox Research Institute has identified the best method for sequencing gene mutations across several o...

All News & Events